Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anhydrous Ceftriaxone Sodium
2. Benaxona
3. Cefatriaxone
4. Cefaxona
5. Ceftrex
6. Ceftriaxon
7. Ceftriaxon Curamed
8. Ceftriaxon Hexal
9. Ceftriaxona Andreu
10. Ceftriaxona Ldp Torlan
11. Ceftriaxone
12. Ceftriaxone Irex
13. Ceftriaxone Sodium
14. Ceftriaxone Sodium, Anhydrous
15. Ceftriaxone, Disodium Salt
16. Ceftriaxone, Disodium Salt, Hemiheptahydrate
17. Lendacin
18. Longacef
19. Longaceph
20. Ro 13 9904
21. Ro 13-9904
22. Ro 139904
23. Ro-13-9904
24. Ro13 9904
25. Ro13-9904
26. Ro139904
27. Rocefalin
28. Rocefin
29. Rocephin
30. Rocephine
31. Tacex
32. Terbac
1. Ceftriaxone Sodium
2. Ceftriaxone
3. 74578-69-1
4. 104376-79-6
5. Ro-139904
6. Ceftriaxone Sodium Salt
7. Octx
8. Ceftriaxone Sodium Trihydrate
9. Schembl537013
10. Chembl1200995
11. Mfcd00941454
12. Akos015961150
13. Ac-1851
14. Disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
15. Sodium (6r,7r)-7-((e)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
16. Sodium;(6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1h-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 576.6 g/mol |
|---|---|
| Molecular Formula | C18H17N8NaO7S3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 8 |
| Exact Mass | 576.02800271 g/mol |
| Monoisotopic Mass | 576.02800271 g/mol |
| Topological Polar Surface Area | 291 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Rocephin |
| PubMed Health | Ceftriaxone (Injection) |
| Drug Classes | Antibiotic |
| Drug Label | Rocephin is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. Ceftriaxone sodium is (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-t... |
| Active Ingredient | Ceftriaxone sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 2 of 2 | |
|---|---|
| Drug Name | Rocephin |
| PubMed Health | Ceftriaxone (Injection) |
| Drug Classes | Antibiotic |
| Drug Label | Rocephin is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. Ceftriaxone sodium is (6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-t... |
| Active Ingredient | Ceftriaxone sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD - Third-generation cephalosporins
J01DD04 - Ceftriaxone
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Parenteral
Fillers, Diluents & Binders
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
91
PharmaCompass offers a list of Ceftriaxone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ceftriaxone manufacturer or Ceftriaxone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ceftriaxone manufacturer or Ceftriaxone supplier.
PharmaCompass also assists you with knowing the Ceftriaxone API Price utilized in the formulation of products. Ceftriaxone API Price is not always fixed or binding as the Ceftriaxone Price is obtained through a variety of data sources. The Ceftriaxone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ceftriaxona LDP Torlan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftriaxona LDP Torlan, including repackagers and relabelers. The FDA regulates Ceftriaxona LDP Torlan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftriaxona LDP Torlan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ceftriaxona LDP Torlan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ceftriaxona LDP Torlan supplier is an individual or a company that provides Ceftriaxona LDP Torlan active pharmaceutical ingredient (API) or Ceftriaxona LDP Torlan finished formulations upon request. The Ceftriaxona LDP Torlan suppliers may include Ceftriaxona LDP Torlan API manufacturers, exporters, distributors and traders.
click here to find a list of Ceftriaxona LDP Torlan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ceftriaxona LDP Torlan DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceftriaxona LDP Torlan active pharmaceutical ingredient (API) in detail. Different forms of Ceftriaxona LDP Torlan DMFs exist exist since differing nations have different regulations, such as Ceftriaxona LDP Torlan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ceftriaxona LDP Torlan DMF submitted to regulatory agencies in the US is known as a USDMF. Ceftriaxona LDP Torlan USDMF includes data on Ceftriaxona LDP Torlan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceftriaxona LDP Torlan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ceftriaxona LDP Torlan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ceftriaxona LDP Torlan Drug Master File in Japan (Ceftriaxona LDP Torlan JDMF) empowers Ceftriaxona LDP Torlan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ceftriaxona LDP Torlan JDMF during the approval evaluation for pharmaceutical products. At the time of Ceftriaxona LDP Torlan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ceftriaxona LDP Torlan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ceftriaxona LDP Torlan Drug Master File in Korea (Ceftriaxona LDP Torlan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ceftriaxona LDP Torlan. The MFDS reviews the Ceftriaxona LDP Torlan KDMF as part of the drug registration process and uses the information provided in the Ceftriaxona LDP Torlan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ceftriaxona LDP Torlan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ceftriaxona LDP Torlan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ceftriaxona LDP Torlan suppliers with KDMF on PharmaCompass.
A Ceftriaxona LDP Torlan CEP of the European Pharmacopoeia monograph is often referred to as a Ceftriaxona LDP Torlan Certificate of Suitability (COS). The purpose of a Ceftriaxona LDP Torlan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ceftriaxona LDP Torlan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ceftriaxona LDP Torlan to their clients by showing that a Ceftriaxona LDP Torlan CEP has been issued for it. The manufacturer submits a Ceftriaxona LDP Torlan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ceftriaxona LDP Torlan CEP holder for the record. Additionally, the data presented in the Ceftriaxona LDP Torlan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ceftriaxona LDP Torlan DMF.
A Ceftriaxona LDP Torlan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ceftriaxona LDP Torlan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ceftriaxona LDP Torlan suppliers with CEP (COS) on PharmaCompass.
A Ceftriaxona LDP Torlan written confirmation (Ceftriaxona LDP Torlan WC) is an official document issued by a regulatory agency to a Ceftriaxona LDP Torlan manufacturer, verifying that the manufacturing facility of a Ceftriaxona LDP Torlan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ceftriaxona LDP Torlan APIs or Ceftriaxona LDP Torlan finished pharmaceutical products to another nation, regulatory agencies frequently require a Ceftriaxona LDP Torlan WC (written confirmation) as part of the regulatory process.
click here to find a list of Ceftriaxona LDP Torlan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ceftriaxona LDP Torlan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ceftriaxona LDP Torlan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ceftriaxona LDP Torlan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ceftriaxona LDP Torlan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ceftriaxona LDP Torlan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ceftriaxona LDP Torlan suppliers with NDC on PharmaCompass.
Ceftriaxona LDP Torlan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceftriaxona LDP Torlan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceftriaxona LDP Torlan GMP manufacturer or Ceftriaxona LDP Torlan GMP API supplier for your needs.
A Ceftriaxona LDP Torlan CoA (Certificate of Analysis) is a formal document that attests to Ceftriaxona LDP Torlan's compliance with Ceftriaxona LDP Torlan specifications and serves as a tool for batch-level quality control.
Ceftriaxona LDP Torlan CoA mostly includes findings from lab analyses of a specific batch. For each Ceftriaxona LDP Torlan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceftriaxona LDP Torlan may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftriaxona LDP Torlan EP), Ceftriaxona LDP Torlan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftriaxona LDP Torlan USP).
